Missing Data Handling in Chronic Pain Trials

被引:39
作者
Kim, Yongman [1 ]
机构
[1] US FDA, Silver Spring, MD 20993 USA
关键词
BOCF; Chronic pain trial; Continuous responder analysis; LOCF; Missing data; Two-part model analysis; LONGITUDINAL CLINICAL-TRIALS;
D O I
10.1080/10543406.2011.550112
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
In chronic pain trials, proper handling of missing data due to dropout is an important issue because the dropout rate is high and the study conclusion may depend on the method chosen. The intent-to-treat (ITT) principle usually requires imputations for missing data to include the dropouts as well as completers in the statistical analysis. However, a statistical analysis with imputation might lead to a misinterpretation of clinical data. In chronic pain trials, treatment-related dropouts are clinical outcomes themselves. For example, an early dropout due to toxicity usually indicates a treatment failure, as does a dropout due to lack of efficacy. Problems with traditional methods such as last observation carried forward (LOCF) or baseline observation carried forward (BOCF) are identified especially in the chronic pain setting. Alternative methods, such as continuous responder analysis and two-part model analysis, treating dropouts as clinical events, are introduced with an example of osteoarthritis clinical trial data.
引用
收藏
页码:311 / 325
页数:15
相关论文
共 9 条
[1]
KIM Y, 2006, 0503 RSR
[2]
Analysis of data with excess zeros [J].
Lachenbruch, PA .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2002, 11 (04) :297-302
[3]
RANDOM-EFFECTS MODELS FOR LONGITUDINAL DATA [J].
LAIRD, NM ;
WARE, JH .
BIOMETRICS, 1982, 38 (04) :963-974
[4]
LASKA E, 2005, STAT ARGUMENT UNPUB
[5]
Lehmann E.L., 1975, NONPARAMETRICS STAT
[6]
LITTLE R. J., 2019, Statistical analysis with missing data, V793
[7]
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data [J].
Mallinckrodt, CH ;
Sanger, TM ;
Dubé, S ;
DeBrota, DJ ;
Molenberghs, G ;
Carroll, RJ ;
Potter, WZ ;
Tollefson, GD .
BIOLOGICAL PSYCHIATRY, 2003, 53 (08) :754-760
[8]
Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials [J].
Mallinckrodt, Craig H. ;
Lane, Peter W. ;
Schnell, Dan ;
Peng, Yahong ;
Mancuso, James P. .
DRUG INFORMATION JOURNAL, 2008, 42 (04) :303-319
[9]
MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets [J].
Siddiqui, Ohidul ;
Hung, H. M. James ;
O'Neill, Robert .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (02) :227-246